2022 Revenues ($USD) : $2,038,000,000
2022 R&D spend : $94,500,000
2022 Number of Employees : 10,025
Fiscal Year End : 12/31/2021
Company CEO : Karim Bitar, CEO

ConvaTec is an advanced wound care, ostomy care, continence and critical care and infusion care company. Founded in 1978, the company's products and devices include DuoDerm dressings, Aquacel and Hydrofiber technology, the Flexi-Seal fecal management system, and the Avelle negative pressure wound therapy system. ConvaTec has shipped more than 1 billion products and operates out of more than 80 countries. In 2022, ConvaTec acquired Triad Life Sciences — now known as Convatec Advanced Tissue Technologies, under Convatec’s Advanced Wound Care business. –DK and JH